{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:19:35Z","timestamp":1792192775473,"version":"4.4.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["1S22722N"],"award-info":[{"award-number":["1S22722N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jconrel.2023.08.054","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T12:22:42Z","timestamp":1693570962000},"page":"268-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Solvent electrospinning amorphous solid dispersions with high itraconazole, celecoxib, mebendazole and fenofibrate drug loading and release potential"],"prefix":"10.1016","volume":"362","author":[{"given":"Jana","family":"Becelaere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olmo","family":"Frateur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Schoolaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Vanhoorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar R.","family":"D'hooge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Vervaet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hoogenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"De Clerck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.08.054_bb0005","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.apsb.2021.05.014","article-title":"Pharmaceutical amorphous solid dispersion: a review of manufacturing strategies","volume":"11","author":"Bhujbal","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejpb.2019.09.005","article-title":"Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs","volume":"144","author":"Boel","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081318","article-title":"Recent technologies for amorphization of poorly water-soluble drugs","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.apsb.2015.07.003","article-title":"Insoluble drug delivery strategies: review of recent advances and business prospects","volume":"5","author":"Kalepu","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/acs.molpharmaceut.5b00798","article-title":"Improved release of celecoxib from high drug loading amorphous solid dispersions formulated with polyacrylic acid and cellulose derivatives","volume":"13","author":"Xie","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2017.11.005","article-title":"Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs","volume":"269","author":"Davis","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/17425247.2014.911728","article-title":"Refining stability and dissolution rate of amorphous drug formulations","volume":"11","author":"Grohganz","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0040","first-page":"1","article-title":"Oral bioavailability enhancement of flubendazole by developing nanofibrous solid dosage forms","volume":"9045","author":"Vigh","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0045","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1021\/nn406388t","article-title":"Drug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s","volume":"8","author":"Schulz","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijpharm.2017.10.051","article-title":"Amorphous solid dispersions and nanocrystal Technologies for Poorly Water-Soluble Drug Delivery \u2013 an update","volume":"535","author":"Jermain","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0055","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1211\/jpp.61.12.0001","article-title":"Review: physical chemistry of solid dispersions","volume":"61","author":"Janssens","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11030136","article-title":"Development and evaluation of poorly water-soluble celecoxib as solid dispersions containing nonionic surfactants using fluidized-bed granulation","volume":"11","author":"Kwon","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0065","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejpb.2018.07.005","article-title":"Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion","volume":"130","author":"Knopp","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2018.12.002","article-title":"Chemically identical but physically different: a comparison of spray drying, hot melt extrusion and cryo-milling for the formulation of high drug loaded amorphous solid dispersions of naproxen","volume":"135","author":"Dedroog","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0075","series-title":"Stable amorphous solid dispersion of flubendazole with high loading via electrospinning","first-page":"123","volume":"351","author":"Becelaere","year":"2022"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejpb.2017.05.008","article-title":"Novel strategies for the formulation and processing of poorly water-soluble drugs","volume":"126","author":"G\u00f6ke","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0085","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1021\/acsnano.8b09651","article-title":"Spinning and applications of bioinspired fiber systems","volume":"13","author":"Shang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105224","article-title":"Recent advances in electrospun nanofibers for some biomedical applications","volume":"144","author":"Sabra","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0095","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1021\/acsnano.0c03981","article-title":"Nanofiber technology for regenerative engineering","volume":"14","author":"Ogueri","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jconrel.2021.03.033","article-title":"Electrospinning for drug delivery applications: a review","volume":"334","author":"Luraghi","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0105","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.biomaterials.2008.01.011","article-title":"Electrospinning: applications in drug delivery and tissue engineering","volume":"29","author":"Sill","year":"2008","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2018.08.016","article-title":"Electrospun amorphous solid dispersions of poorly water-soluble drugs: a review","volume":"292","author":"Yu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2017.07.001","article-title":"Electrospun polymeric nanofibers: new horizons in drug delivery","volume":"107","author":"Thakkar","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0120","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1021\/acs.molpharmaceut.8b00043","article-title":"Manufacturing amorphous solid dispersions with a tailored amount of crystallized API for biopharmaceutical testing","volume":"15","author":"Theil","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0125","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1021\/acs.molpharmaceut.9b00452","article-title":"Effect of variability of physical properties of povidone K30 on crystallization and drug-polymer miscibility of celecoxib-povidone K30 amorphous solid dispersions","volume":"16","author":"Phadke","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1021\/acs.molpharmaceut.1c00578","article-title":"Insights into the release mechanisms of ITZ:HPMCAS amorphous solid dispersions: the role of drug-rich colloids","volume":"19","author":"Nunes","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0135","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejpb.2010.04.009","article-title":"Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole","volume":"75","author":"Van Speybroeck","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2018.02.005","article-title":"Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion","volume":"540","author":"Bhardwaj","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0145","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1021\/acs.molpharmaceut.9b01109","article-title":"Formulating amorphous solid dispersions: impact of inorganic salts on drug release from tablets containing Itraconazole-HPMC Extrudate","volume":"17","author":"Takano","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijpharm.2017.01.043","article-title":"Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: effect of constituent compositions","volume":"519","author":"Davis","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0155","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejps.2010.09.002","article-title":"Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica","volume":"41","author":"Van Speybroeck","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118661","article-title":"Immediate-released pelletized solid dispersion containing fenofibrate: formulation, in vitro characterization, and bioequivalence studies in experimental beagle dogs","volume":"570","author":"Nguyen","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejps.2019.01.019","article-title":"Hot melt extrusion technology for improved dissolution, solubility and \u201cspring-parachute\u201d processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: profiles and mechanisms","volume":"130","author":"Shi","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2010.10.002","article-title":"Changed crystallinity of mebendazole solid dispersion: improved anthelmintic activity","volume":"403","author":"Garc\u00eda-Rodriguez","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0175","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/07373937.2015.1090447","article-title":"Development of self-microemulsifying drug delivery system of mebendazole by spray drying technology: characterization, in vitro and in vivo evaluation","volume":"34","author":"Parakh","year":"2016","journal-title":"Dry. Technol."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0180","first-page":"1","article-title":"Preparation, physicochemical characterization and in vitro and in vivo activity against Heligmosomoides polygyrus of novel oral formulations of Albendazole and mebendazole","author":"Buchter","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105242","article-title":"Insight into the colonic disposition of celecoxib in humans","volume":"145","author":"Lemmens","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2018.11.050","article-title":"Amorphous multi-system of celecoxib improves its anti-inflammatory activity in vitro and oral absorption in rats","volume":"555","author":"Choi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0195","doi-asserted-by":"crossref","first-page":"15400","DOI":"10.1002\/anie.201807796","article-title":"Defined high molar mass poly(2-Oxazoline)s","volume":"57","author":"Monnery","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0200","first-page":"35","article-title":"ICH guideline Q3C (R6) on impurities: guideline for residual solvents","volume":"68","author":"EMEA","year":"2016","journal-title":"Int. Conf. Harmon."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0205","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ijpharm.2017.08.121","article-title":"Moisture-induced phase separation and recrystallization in amorphous solid dispersions","volume":"532","author":"Luebbert","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0210","doi-asserted-by":"crossref","first-page":"17331","DOI":"10.1039\/c1jm12541a","article-title":"Water uptake of poly(2-N-alkyl-2-oxazoline)s: influence of crystallinity and hydrogen-bonding on the mechanical properties","volume":"21","author":"Rettler","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0215","series-title":"Fundamental Principles of Polymeric Materials","author":"Brazel","year":"2012"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.xphs.2016.06.017","article-title":"Effect of temperature and moisture on the physical stability of binary and ternary amorphous solid dispersions of celecoxib","volume":"106","author":"Xie","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.xphs.2017.10.028","article-title":"Moisture-induced amorphous phase separation of amorphous solid dispersions: molecular mechanism, microstructure, and its impact on dissolution performance","volume":"107","author":"Chen","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0230","doi-asserted-by":"crossref","first-page":"12698","DOI":"10.1021\/acs.iecr.7b03187","article-title":"Effect of API-polymer miscibility and interaction on the stabilization of amorphous solid dispersion: a molecular simulation study","volume":"56","author":"Yani","year":"2017","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0235","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.addr.2011.07.009","article-title":"Evaluation of amorphous solid dispersion properties using thermal analysis techniques","volume":"64","author":"Baird","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0240","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/jps.22074","article-title":"Drug\u2013polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development","volume":"99","author":"Qian","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0245","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.reactfunctpolym.2010.07.018","article-title":"Synthesis and characterization of side-chain oxazoline\u2013methyl methacrylate copolymers bearing azo-dye","volume":"70","author":"Jerca","year":"2010","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0250","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0032-3861(96)00652-0","article-title":"The glass transition temperature of random copolymers: 2. Extension of the Gordon-Taylor equation for asymmetric Tg vs composition curves","volume":"38","author":"Schneider","year":"1997","journal-title":"Polymer (Guildf)"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0255","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2010.05.033","article-title":"Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?","volume":"395","author":"Qian","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0260","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5254\/1.3539818","article-title":"Ideal copolymers and the second-order transitions of synthetic rubbers. I. Noncrystalline copolymers","volume":"26","author":"Gordon","year":"1953","journal-title":"Rubber Chem. Technol."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.xphs.2017.09.030","article-title":"Predicting solubility \/ miscibility in amorphous dispersions: it is time to move beyond regular solution theories","volume":"107","author":"Anderson","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0270","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1080\/17425247.2016.1198769","article-title":"The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers","volume":"13","author":"Van Duong","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0275","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2012.02.004","article-title":"Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions","volume":"81","author":"L\u00f6bmann","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0280","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1021\/acs.macromol.0c00282","article-title":"Block copolymers composed of PEtOx and Polyesteramides based on glycolic acid, l-valine, and l-isoleucine","volume":"53","author":"Dirauf","year":"2020","journal-title":"Macromolecules."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0285","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1021\/acs.molpharmaceut.7b00735","article-title":"Extraordinary long-term-stability in kinetically stabilized amorphous solid dispersions of Fenofibrate","volume":"14","author":"Theil","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0290","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejps.2016.01.026","article-title":"Influence of PVP\/VA copolymer composition on drug-polymer solubility","volume":"85","author":"Rask","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0295","series-title":"Introduction to Polymers","author":"Young","year":"2011"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0300","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/macp.200350002","article-title":"Chain connectivity and conformational variability of polymers: clues to an adequate thermodynamic description of their solutions, 2. Composition dependence of Flory-Huggins interaction parameters","volume":"204","author":"Wolf","year":"2003","journal-title":"Macromol. Chem. Phys."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0305","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1021\/acs.macromol.0c00970","article-title":"Immiscibility of chemically alike amorphous polymers: phase separation of poly(2-ethyl-2-oxazoline) and poly(2- n-propyl-2-oxazoline)","volume":"53","author":"Schoolaert","year":"2020","journal-title":"Macromolecules."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0310","series-title":"Properties of polymers. Their correlation with chemical structure; their numerical estimation and prediction from additive group contributions","author":"van Krevelen","year":"2009"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0315","series-title":"Hansen Solubility Parameters","author":"Hansen","year":"2007"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0320","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-017-2313-1","article-title":"Synergistic effect of polyvinyl alcohol and Copovidone in Itraconazole amorphous solid dispersions","volume":"35","author":"Wlodarski","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0325","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijpharm.2018.11.063","article-title":"Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole","volume":"555","author":"Zhang","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0330","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S1773-2247(14)50097-4","article-title":"Tracking of the solubility enhancement and drug release stability of melt extrudates containing mebendazole","volume":"24","author":"K\u00e1llai-Szab\u00f3","year":"2014","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0335","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.msec.2016.11.042","article-title":"Anomalous dissolution behavior of celecoxib in PVP\/Isomalt solid dispersions prepared using spray drier","volume":"72","author":"Ghanavati","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2023.08.054_bb0340","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jddst.2018.05.020","article-title":"Preparation and characterization of solid dispersions of celecoxib obtained by spray-drying ethanolic suspensions containing PVP-K30 or isomalt","volume":"46","author":"Motallae","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0345","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejps.2018.09.006","article-title":"Development of controlled release amorphous solid dispersions (CRASD) using polyvinyl acetate-based release retarding materials: effect of dosage form design","volume":"124","author":"Lugtu-Pe","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0350","article-title":"Stable amorphous solid dispersions of fenofibrate using hot melt extrusion technology: effect of formulation and process parameters for a low glass transition temperature drug","volume":"58","author":"Kallakunta","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0355","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijpharm.2019.04.051","article-title":"Improvement of the dissolution rate and bioavailability of fenofibrate by the supercritical anti-solvent process","volume":"564","author":"Bin Ahn","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.054_bb0360","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.apt.2017.02.020","article-title":"Solvent-free direct formulation of poorly-soluble drugs to amorphous solid dispersion via melt-absorption","volume":"28","author":"Shen","year":"2017","journal-title":"Adv. Powder Technol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:42:55Z","timestamp":1777509775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923005540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":72,"alternative-id":["S0168365923005540"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.054","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solvent electrospinning amorphous solid dispersions with high itraconazole, celecoxib, mebendazole and fenofibrate drug loading and release potential","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}